BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2960493)

  • 1. Multi-centre open study of a triphasic levonorgestrel-ethinyloestradiol combined oral contraceptive ('Trinordiol').
    Butler AJ; Green A; Cohen M
    Curr Med Res Opin; 1987; 10(8):503-13. PubMed ID: 2960493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
    Gaspard UJ; Deville JL; Dubois M
    Curr Med Res Opin; 1983; 8(6):395-404. PubMed ID: 6406157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year, multicenter study of a triphasic, low-dose, combination oral contraceptive.
    Woutersz TB; Korba VD
    Int J Fertil; 1988; 33(6):406-10. PubMed ID: 2906915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
    Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT
    Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A; Dewailly SD; Grenier R; Huard J
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
    Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical comparison of two triphasic oral contraceptives with levonorgestrel or norethindrone: a prospective, randomized, single-blind study.
    Masson S; Franssen E; Hilditch JR; Powell MG
    Contraception; 1993 Jan; 47(1):43-54. PubMed ID: 8436001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a new triphasic oral contraceptive in private practice.
    Ellsworth HS; Ayerst RI; Harris JW; Stone RA; Anderson AE; Jones TL; Curtis MK
    Contraception; 1986 Nov; 34(5):435-42. PubMed ID: 3102161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version.
    Carlborg L
    Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with a triphasic oral contraceptive.
    Ulstein M; Svendsen E; Steier A; Bratt H; Fylling P; Lie S; Schiefloe A; Aaserud J
    Acta Obstet Gynecol Scand; 1984; 63(3):233-6. PubMed ID: 6428157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial.
    Schilling LH; Bolding OT; Chenault CB; Chong AP; Fleury F; Forrest K; Glick HI; Hasson HM; Heil CG; London RS
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1264-8. PubMed ID: 2655451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three and one-half years' experience with a lower-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1976 Jun; 16(6):338-44. PubMed ID: 957360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter clinical investigation employing ethinyl estradiol combined with dl-norgestrel as postcoital contraceptive agent.
    Yuzpe AA; Smith RP; Rademaker AW
    Fertil Steril; 1982 Apr; 37(4):508-13. PubMed ID: 7040117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter comparative trial of triphasic and monophasic, low-dose combined oral contraceptives.
    Dunson TR; McLaurin VL; Aguayo EL; de Silva P; Calventi V; Gerais AS; Serani RG
    Contraception; 1993 Jun; 47(6):515-25. PubMed ID: 8334888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraception, 1986. Focus on Triphasil.
    Ellsworth H
    J Reprod Med; 1986 Jun; 31(6 Suppl):559-64. PubMed ID: 3522896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
    Prasad RN; Liew D; Ratnam SS
    Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives.
    Nielsen CH; Poulsen HK; Teisner B; Thorsen P; Hau J; Westergaard JG
    Eur J Obstet Gynecol Reprod Biol; 1993 Sep; 51(1):63-71. PubMed ID: 7506680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.